The purpose of this study is to evaluate the inpatient pain medication use of patients who had a revision shoulder arthroplasty procedure performed and compare them to a cohort of patients who had a primary reverse total shoulder arthroplasty (rTSA) performed to determine whether revision shoulder arthroplasty requires more pain medication..
A retrospective review was performed on patients undergoing revision arthroplasty (n = 75) and primary rTSA (n = 340). Inpatient medication records were reviewed to tabulate the visual analog pain (VAS) all narcotic medication use, and total morphine equivalent units (MEUs) were calculated for the duration of the inpatient stay.
There was no significant difference between groups regarding age, sex, body mass index, Charlson Comorbidity Index, American Society of Anesthesiologists score, preoperative narcotic pain medication use, tobacco use, postoperative VAS scores or hospital length of stay. There were no predictors of total postoperative MEUs identified. Overall, patients in the revision arthroplasty group received significantly less total MEUs than those in the primary rTSA group, 134.96 MEUs vs. 69.79 MEUs, respectively (p < .0005).
The perceived notion that revision shoulder arthroplasty is more painful may cause providers to be more inclined to increase narcotic use, or use more invasive pain control techniques. Based on these data, we found that revision shoulder arthroplasty did not require an increased opioid requirement, longer length of stay or increase VAS, suggesting that these patients can often be managed similarly to primary rTSA.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Cofield RH, Edgerton BC (1990) Total shoulder arthroplasty: complications and revision surgery. Instr Course Lect 39:449–462
Harjula JNE, Paloneva J, Haapakoski J, Kukkonen J, Aarimaa V (2018) Increasing incidence of primary shoulder arthroplasty in Finland - a nationwide registry study. BMC Musculoskelet Disord 19(1):245. https://doi.org/10.1186/s12891-018-2150-3
Kim SH, Wise BL, Zhang Y, Szabo RM (2011) Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am 93(24):2249–2254. https://doi.org/10.2106/JBJS.J.01994
Wirth MA, Rockwood CA Jr (1996) Complications of total shoulder-replacement arthroplasty. J Bone Joint Surg Am 78(4):603–616. https://doi.org/10.2106/00004623-199604000-00018
Jaeger P, Koscielniak-Nielsen ZJ, Schroder HM, Mathiesen O, Henningsen MH, Lund J, Jenstrup MT, Dahl JB (2014) Adductor canal block for postoperative pain treatment after revision knee arthroplasty: a blinded, randomized, placebo-controlled study. PLoS ONE 9(11):e111951. https://doi.org/10.1371/journal.pone.0111951
Bernstein J, Feng J, Mahure S, Schwarzkopf R, Long W (2020) Revision total knee arthroplasty is associated with significantly higher opioid consumption as compared with primary total knee arthroplasty in the acute postoperative period. Arthroplast Today 6(2):172–175. https://doi.org/10.1016/j.artd.2020.04.001
Ullah H, Samad K, Khan FA (2014) Continuous interscalene brachial plexus block versus parenteral analgesia for postoperative pain relief after major shoulder surgery. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007080.pub2
Prevention CoDCa. https://www.cdc.gov/opioids/providers/prescribing/guideline.html. 2021
Peres-da-Silva A, Kleeman LT, Wellman SS, Green CL, Attarian DE, Bolognesi MP, Seyler TM (2017) What factors drive inpatient satisfaction after knee arthroplasty? J Arthroplast 32(6):1769–1772. https://doi.org/10.1016/j.arth.2017.01.036
Sheetz KH, Waits SA, Girotti ME, Campbell DA Jr, Englesbe MJ (2014) Patients’ perspectives of care and surgical outcomes in Michigan: an analysis using the CAHPS hospital survey. Ann Surg 260(1):5–9. https://doi.org/10.1097/SLA.0000000000000626
Alexander GC, Kruszewski SP, Webster DW (2012) Rethinking opioid prescribing to protect patient safety and public health. JAMA 308(18):1865–1866. https://doi.org/10.1001/jama.2012.14282
Zgierska A, Miller M, Rabago D (2012) Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA 307(13):1377–1378. https://doi.org/10.1001/jama.2012.419
Bartels K, Mayes LM, Dingmann C, Bullard KJ, Hopfer CJ, Binswanger IA (2016) Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS ONE 11(1):e0147972. https://doi.org/10.1371/journal.pone.0147972
Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL (2017) Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg 152(11):1066–1071. https://doi.org/10.1001/jamasurg.2017.0831
Singh JA, Sperling JW, Cofield RH (2011) Revision surgery following total shoulder arthroplasty: analysis of 2588 shoulders over three decades (1976 to 2008). J Bone Joint Surg Br 93(11):1513–1517. https://doi.org/10.1302/0301-620X.93B11.26938
Holcomb JO, Cuff D, Petersen SA, Pupello DR, Frankle MA (2009) Revision reverse shoulder arthroplasty for glenoid baseplate failure after primary reverse shoulder arthroplasty. J Shoulder Elbow Surg 18(5):717–723. https://doi.org/10.1016/j.jse.2008.11.017
Ortmaier R, Resch H, Matis N, Blocher M, Auffarth A, Mayer M, Hitzl W, Tauber M (2013) Reverse shoulder arthroplasty in revision of failed shoulder arthroplasty-outcome and follow-up. Int Orthop 37(1):67–75. https://doi.org/10.1007/s00264-012-1742-z
Patel DN, Young B, Onyekwelu I, Zuckerman JD, Kwon YW (2012) Reverse total shoulder arthroplasty for failed shoulder arthroplasty. J Shoulder Elbow Surg 21(11):1478–1483. https://doi.org/10.1016/j.jse.2011.11.004
Boileau P, Melis B, Duperron D, Moineau G, Rumian AP, Han Y (2013) Revision surgery of reverse shoulder arthroplasty. J Shoulder Elbow Surg 22(10):1359–1370. https://doi.org/10.1016/j.jse.2013.02.004
Saltzman BM, Chalmers PN, Gupta AK, Romeo AA, Nicholson GP (2014) Complication rates comparing primary with revision reverse total shoulder arthroplasty. J Shoulder Elbow Surg 23(11):1647–1654. https://doi.org/10.1016/j.jse.2014.04.015
Menendez ME, Lawler SM, Ring D, Jawa A (2018) High pain intensity after total shoulder arthroplasty. J Shoulder Elbow Surg 27(12):2113–2119. https://doi.org/10.1016/j.jse.2018.08.001
Bot AG, Bekkers S, Arnstein PM, Smith RM, Ring D (2014) Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief. Clin Orthop Relat Res 472(8):2542–2549. https://doi.org/10.1007/s11999-014-3660-4
Nota SP, Spit SA, Voskuyl T, Bot AG, Hageman MG, Ring D (2015) Opioid use, satisfaction, and pain intensity after orthopedic surgery. Psychosomatics 56(5):479–485. https://doi.org/10.1016/j.psym.2014.09.003
Bolz NJ, Iorio R (2016) Bundled payments: our experience at an academic medical center. J Arthroplasty 31(5):932–935. https://doi.org/10.1016/j.arth.2016.01.055
Rao AG, Chan PH, Prentice HA, Paxton EW, Navarro RA, Dillon MT, Singh A (2018) Risk factors for postoperative opioid use after elective shoulder arthroplasty. J Shoulder Elbow Surg 27(11):1960–1968. https://doi.org/10.1016/j.jse.2018.04.018
Boddu C, Genza A, McCann PD (2018) Bridging multimodal pain management provides 48-hour pain control in patients undergoing total shoulder replacement. J Shoulder Elbow Surg 27(6S):S65–S69. https://doi.org/10.1016/j.jse.2017.12.026
Codding JL, Getz CL (2018) Pain management strategies in shoulder arthroplasty. Orthop Clin North Am 49(1):81–91. https://doi.org/10.1016/j.ocl.2017.08.010
McLaughlin DC, Cheah JW, Aleshi P, Zhang AL, Ma CB, Feeley BT (2018) Multimodal analgesia decreases opioid consumption after shoulder arthroplasty: a prospective cohort study. J Shoulder Elbow Surg 27(4):686–691. https://doi.org/10.1016/j.jse.2017.11.015
Goebel S, Stehle J, Schwemmer U, Reppenhagen S, Rath B, Gohlke F (2010) Interscalene brachial plexus block for open-shoulder surgery: a randomized, double-blind, placebo-controlled trial between single-shot anesthesia and patient-controlled catheter system. Arch Orthop Trauma Surg 130(4):533–540. https://doi.org/10.1007/s00402-009-0985-7
Hofmann-Kiefer K, Eiser T, Chappell D, Leuschner S, Conzen P, Schwender D (2008) Does patient-controlled continuous interscalene block improve early functional rehabilitation after open shoulder surgery? Anesth Analg 106(3):991–996. https://doi.org/10.1213/ane.0b013e31816151ab
Kean J, Wigderowitz CA, Coventry DM (2006) Continuous interscalene infusion and single injection using levobupivacaine for analgesia after surgery of the shoulder. A double-blind, randomised controlled trial. J Bone Joint Surg Br 88(9):1173–1177. https://doi.org/10.1302/0301-620X.88B9.17412
Ilfeld BM, Vandenborne K, Duncan PW, Sessler DI, Enneking FK, Shuster JJ, Theriaque DW, Chmielewski TL, Spadoni EH, Wright TW (2006) Ambulatory continuous interscalene nerve blocks decrease the time to discharge readiness after total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study. Anesthesiology 105(5):999–1007. https://doi.org/10.1097/00000542-200611000-00022
Buise MP, Bouwman RA, van der Gaag A, Piot V, Korsten HH (2015) Phrenic nerve palsy following interscalene brachial plexus block; a long lasting serious complication. Acta Anaesthesiol Belg 66(3):91–94
Oh JH, Rhee KY, Kim SH, Lee PB, Lee JW, Lee SJ (2009) Comparison of analgesic efficacy between single interscalene block combined with a continuous intra-bursal infusion of ropivacaine and continuous interscalene block after arthroscopic rotator cuff repair. Clin Orthop Surg 1(1):48–53. https://doi.org/10.4055/cios.2009.1.1.48
Sabesan VJ, Shahriar R, Petersen-Fitts GR, Whaley JD, Bou-Akl T, Sweet M, Milia M (2017) A prospective randomized controlled trial to identify the optimal postoperative pain management in shoulder arthroplasty: liposomal bupivacaine versus continuous interscalene catheter. J Shoulder Elbow Surg 26(10):1810–1817. https://doi.org/10.1016/j.jse.2017.06.044
The authors did not receive support from any organization for the submitted work.
Conflict of interest
Financial interests: Dr. Stephen A. Parada is a consultant and receives institutional research support from Exactech, Inc. (Gainesville, FL) He is a consultant for Arthrex, Inc. Dr. Lynn A. Crosby is a consultant for Exactech, Inc. Nonfinancial interests: Dr. Stephen A. Parada is a committee member for AAOS and ASES.
IRB approved [1324930-6].
Consent for publication
All authors have approved the publication.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gage Griswold, B., Fielding Callaway, L., Meng, M.R.I. et al. Opioid requirements in primary versus revision reverse shoulder arthroplasty. Eur J Orthop Surg Traumatol (2021). https://doi.org/10.1007/s00590-021-03121-x
- Practice management
- Shoulder arthroplasty
- Pain management